Clinical Trials List
2011-01-10 - 2013-06-30
Phase II
Terminated4
-
Trial Applicant
NOVARTIS (TAIWAN) CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Chih-Hung Hsu Division of Hematology & Oncology
- Ying-Chun Shen Division of Hematology & Oncology
- Chiun Hsu Division of Hematology & Oncology
- - - Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 葉宏仁 Digestive System Department
- TENG-YU LEE Digestive System Department
- Sheng-Shun Yang Digestive System Department
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Ming-Huang Chen Division of Hematology & Oncology
- Chung-Pin Li Digestive System Department
- Rheun-Chuan Lee Division of Radiology
- Yi-Hsiang Huang Digestive System Department
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Jen-Shi Chen Division of Hematology & Oncology
- Chi-Ting Liau Division of Hematology & Oncology
- Hung-Chih Hsu Division of Hematology & Oncology
- Wen-Chi Shen Division of Hematology & Oncology
- Ming-Mo Hou Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
40 participants
-
Global
150 participants
